Hikma Pharmaceuticals Expands US Collaboration With Arecor
Hikma Pharmaceuticals Expands US Collaboration With Arecor
Read moreThu, 12th May 2016 12:07
Hikma Pharmaceuticals Expands US Collaboration With Arecor
Read moreUK BROKER RATINGS SUMMARY: Goldman Raises Coca-Cola HBC And Cuts DCC
Read moreIN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback
Read moreLONDON MARKET CLOSE: Stocks Rebound Slightly As Covid-19 Fears Remain
Read moreUK WINNERS & LOSERS SUMMARY: Beazley's Virus Claims Estimate Doubles
Read moreHikma Expects To Gain FDA Approval For Advair Diskus In Early 2021
Read moreLONDON MARKET OPEN: FTSE Bounces Back But Travel Stocks Under Pressure
Read more(Sharecast News) - Hikma Pharmaceuticals lowered its guidance for 2020 on Tuesday, following a response letter from the US Food and Drug Administration (FDA) over the abbreviated new drug application for its generic version of GlaxoSmithKline's 'Advair Diskus', or fluticasone propionate and salmeterol inhalation powder, it announced on Tuesday.
Read moreLONDON MARKET PRE-OPEN: Whitbread Sales Slump, Plans To Axe 6,000 Jobs
Read more* EMA says drug could be option for severely ill patients* Recommends dosage of 6 mg once a day for up to 10 days* Gilead's Veklury already approved for COVID-19 in EU (Recasts, adds details on drug, background)By Pushkala Aripaka and Yadarisa Shabo...
Read moreUK BROKER RATINGS SUMMARY: Barclays Cuts GVC And Raises Flutter
Read moreLONDON MARKET CLOSE: Housebuilders Drag FTSE 100 Into Red
Read more(Sharecast News) - Imperial Brands: JP Morgan upgrades to overweight with a target price of 1,650.0p.
Read moreLONDON MARKET MIDDAY: Stocks Rise As All Eyes Turn To US Jobs Report
Read more